Tests Predict if Procrit, Aranesp or Epogen Will Speed Tumor Growth
Study Says Genetic Tests May Predict if Procrit. Some cancer patients treated with the anemia drugs Procrit, Aranesp and Epogen could experience increased tumor growth. However, researcher recently reported that there may be a way to predict which cancer patients are at risk for this devastating side effect. Procrit, Aranesp and … [Read more...]
FDA Updates Coumadin Label to Warn of Genetic Risks
Popular Blood Thinner Coumadin Label Update. The Food & Drug Administration (FDA) has approved a label update for a popular blood thinner. The new label for Coumadin will warn doctors that patients with specific genetic make-ups might not respond well to the drug. The FDA says that about 30 percent of the patients who take … [Read more...]
